These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3306039)

  • 1. [Platelet factor 3].
    Isobe J
    Rinsho Byori; 1987 Jun; Spec No 71():183-91. PubMed ID: 3306039
    [No Abstract]   [Full Text] [Related]  

  • 2. [The determination of platelet factor 3 using hirudin].
    Wamhoff D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):82-7. PubMed ID: 50972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet factor 3 (PF3) and primary hemostasis: ditazol test].
    Di Micco B; Boeri F; Pagliara E; Cinque MR; Messina MF; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):237-43. PubMed ID: 44904
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
    Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
    Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombocyte functions in diabetics with proliferative retinopathy and in normal persons].
    Peters KM; Reuter HD
    Med Klin (Munich); 1986 Jun; 81(14):477-80. PubMed ID: 3785033
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of primary hemostasis and the coagulative pathway].
    Di Micco B; Cinque MR; Pagliara E; Ciccone S; Messina MF; De Felice MG; Del Guercio R; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):219-26. PubMed ID: 44903
    [No Abstract]   [Full Text] [Related]  

  • 8. [Potassium, magnesium, copper, manganese and cobalt salts of aspartic acid on platelet factor 3 availability (author's transl)].
    Reuter HD; Schröter G
    Arzneimittelforschung; 1980; 30(12):2106-8. PubMed ID: 7194069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased platelet aggregation, Ca2+ and Mg2+ ATPase and platelet factor 3 activities in patients with Wilson disease.
    Cohen AM; Brettbart H; Creter D; Levinsky H; Frydman M; Djaldetti M
    Haematologica; 1984; 69(3):263-71. PubMed ID: 6147299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Platelet factor 3 and 4 in juvenile diabetes and in children of diabetic mothers].
    Calabrese S; Giansante C; Burigana F; Feruglio FS
    Minerva Med; 1981 Sep; 72(34):2255-60. PubMed ID: 7290451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardized bioassay for platelet factor 3 released by kaolin.
    Pérez-Requejo JL
    Br J Haematol; 1976 May; 33(1):39-51. PubMed ID: 1268089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-platelet antibody determination by platelet factor 3 assay.
    Okuno T; Crockatt D
    Am J Clin Pathol; 1976 Sep; 66(3):475-8. PubMed ID: 961626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood platelet proteases and their role in platelet protein degradation and platelet coagulation factor inactivation].
    Ostrowska H; Worowski K
    Acta Haematol Pol; 1981; 12(1):17-21. PubMed ID: 7032177
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease.
    Famodu AA; Oduwa D
    Br J Biomed Sci; 1995 Dec; 52(4):323-4. PubMed ID: 8555788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet factor 3 availability induced by phorbol-12-myristate-13-acetate.
    Jerushalmy Z; Englender T; Shaklai M
    Thromb Haemost; 1984 Oct; 52(2):218. PubMed ID: 6523439
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standardization of the method for the determination of the platelet factor 4 in plasms and serum].
    Domingo Albos A; Domenech Mateu MD; Castillo Cofiño R
    Sangre (Barc); 1972; 17(4):479-83. PubMed ID: 4671004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of platelet factor 3 during central thrombocytopenia].
    Sultan Y; Scrobohaci ML; Jaillet N; Caen JP
    Nouv Rev Fr Hematol; 1973; 13(4):549-53. PubMed ID: 4271104
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of cis-platinum on some platelet functions in vitro.
    Kubisz P; Seghier F; Klener P; Holan J
    Neoplasma; 1983; 30(4):391-4. PubMed ID: 6684214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.